Premenstrual symptoms are extremely common among women of reproductive age. As many as 75% of women report minor or isolated premenstrual symptoms, up to 50% of women are estimated to have premenstrual syndrome (PMS), and 3% to 5% of women are considered to have severe PMS or premenstrual dysphoric disorder (PMDD) [1,2]. PMDD has been defined as a psychophysiological disorder in which both soma...

Several lines of investigation suggest that obsessivecompulsive disorder (OCD) may be associated with serotonergic dysfunction. Researchers have also suggested that serotonin plays an important role in the migraine headache process. However, there are few published reports examining the relation between clinical OCD and migraine headache. Researchers have suggested that the migraine headache sy...

Introduction: Medical undergraduates are heavily burdened by their curriculum. The females, in addition, suffer from vivid affective or somatic premenstrual syndrome (PMS) symptoms such as bloating, mastalgia, insomnia, fatigue, mood swings, irritability, and depression. The present study was proposed to attenuate the symptoms of PMS by simple lifestyle measures like yoga and/or oral calcium. M...

OBJECTIVE This review synthesizes available evidence for managing clinically significant dysphoric symptoms encountered in primary care, when formal criteria for major depression or dysthymia are not met. Discussion is focused on premenstrual dysphoric disorder (PMDD) and minor depression because of their significant prevalence in the primary care setting and the lack of clear practice guidelin...

This is the first study to assess prevalence of symptoms premenstrual dysphoric disorder (PMDD), episodes postpartum depression (PPD) after childbirth, and climacteric mood in Attention-Deficit/Hyperactivity Disorder (ADHD). 209 consecutive women (18–71 years) with ADHD completed PMDD chapter Neuropsychiatric Interview Plus version 5.0.0 PMDD, Edinburgh Postnatal Depression Scale PPD, Greene Cl...

show at least a 30% increase from the intensity of symptoms measured in the follicular phase, that is, in days 5–10 of the menstrual cycle, compared with those measured in the premenstrual phase (on the 6 days before menstruation). In addition, premenstrual changes must be prospectively documented for at least two consecutive menstrual cycles. Some research authorities stipulate a 50% worsening...

OBJECTIVES To investigate (i) the differential changes in premenstrual symptoms, mood, cognitions, and coping strategies during two treatments [cognitive-behavioural therapy (CBT) and fluoxetine] for premenstrual dysphoric disorder (PMDD) and (ii) the characteristics of those with good vs. poor outcome post treatment and at 1 year follow-up. METHODS Premenstrual symptoms, mood (Hospital Anxie...